Two units of
Eagle and the Teva subsidiaries—Teva Pharmaceuticals International GmbH and Cephalon LLC—sued Montreal-based BendaRx Corp. on May 4 in the US District Court for the District of Delaware.
The next day, they filed an amended complaint after lawyers for BendaRx Corp. in Canada said the company’s regulatory notice letter “contained an error and should have identified ‘BendaRx USA Corp.,’ not ‘BendaRx Corp.’ as the submitter” ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.